Avantor, Inc. Earnings Per Share (Diluted)
Avantor, Inc. (AVTR) reported Earnings Per Share (Diluted) of $0.06 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-04-29
- Avantor, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $0.06, a 33.33% decline year-over-year.
- Avantor, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $0.08, a 89.48% decline year-over-year.
- Avantor, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$1.04, a 1400.00% decline year-over-year.
- Avantor, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was $0.09, a 35.71% decline year-over-year.
- Avantor, Inc. earnings per share, diluted for fiscal 2025 was -$0.78, a 175.00% decline from fiscal 2024.
- Avantor, Inc. earnings per share, diluted for fiscal 2024 was $1.04, a 121.28% increase from fiscal 2023.
- Avantor, Inc. earnings per share, diluted for fiscal 2023 was $0.47, a 53.47% decline from fiscal 2022.
- Avantor, Inc. earnings per share, diluted for fiscal 2022 was $1.01, a 18.82% increase from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-03-31 | $0.06 10-Q · filed 2026-04-29 | $0.14 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-04-29 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2025-12-31 | $0.08 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-02-11 | -$0.78 10-K · filed 2026-02-11 |
| 2025-09-30 | -$1.04 10-Q · filed 2025-10-29 | -$0.95 derived: net income ÷ weighted average shares · filed 2025-10-29 | -$0.86 10-Q · filed 2025-10-29 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2025-06-30 | $0.09 10-Q · filed 2025-08-01 | $0.19 10-Q · filed 2025-08-01 | $0.92 derived: net income ÷ weighted average shares · filed 2026-04-29 | $1.01 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2025-03-31 | $0.09 10-Q · filed 2026-04-29 | $0.83 derived: net income ÷ weighted average shares · filed 2026-04-29 | $0.91 derived: net income ÷ weighted average shares · filed 2026-04-29 | $1.05 derived: net income ÷ weighted average shares · filed 2026-04-29 |
| 2024-12-31 | $0.73 derived: net income ÷ weighted average shares · filed 2026-02-11 | $0.82 derived: net income ÷ weighted average shares · filed 2026-02-11 | $0.95 derived: net income ÷ weighted average shares · filed 2026-02-11 | $1.04 10-K · filed 2026-02-11 |
| 2024-09-30 | $0.08 10-Q · filed 2025-10-29 | $0.22 derived: net income ÷ weighted average shares · filed 2025-10-29 | $0.31 10-Q · filed 2025-10-29 | $0.45 derived: net income ÷ weighted average shares · filed 2026-02-11 |
| 2024-06-30 | $0.14 10-Q · filed 2025-08-01 | $0.22 10-Q · filed 2025-08-01 | $0.37 derived: net income ÷ weighted average shares · filed 2026-02-11 | $0.53 derived: net income ÷ weighted average shares · filed 2026-02-11 |
| 2024-03-31 | $0.09 10-Q · filed 2025-04-25 | $0.23 derived: net income ÷ weighted average shares · filed 2026-02-11 | $0.39 derived: net income ÷ weighted average shares · filed 2026-02-11 | $0.38 derived: net income ÷ weighted average shares · filed 2026-02-11 |
| 2023-12-31 | $0.15 derived: net income ÷ weighted average shares · filed 2026-02-11 | $0.30 derived: net income ÷ weighted average shares · filed 2026-02-11 | $0.29 derived: net income ÷ weighted average shares · filed 2026-02-11 | $0.47 10-K · filed 2026-02-11 |
| 2023-09-30 | $0.16 10-Q · filed 2024-10-25 | $0.15 derived: net income ÷ weighted average shares · filed 2024-10-25 | $0.33 10-Q · filed 2024-10-25 | $0.54 derived: net income ÷ weighted average shares · filed 2025-02-07 |
| 2023-06-30 | -$0.01 10-Q · filed 2024-07-26 | $0.17 10-Q · filed 2024-07-26 | $0.38 derived: net income ÷ weighted average shares · filed 2025-02-07 | $0.62 derived: net income ÷ weighted average shares · filed 2025-02-07 |
| 2023-03-31 | $0.18 10-Q · filed 2024-04-26 | $0.39 derived: net income ÷ weighted average shares · filed 2025-02-07 | $0.63 derived: net income ÷ weighted average shares · filed 2025-02-07 | $0.91 derived: net income ÷ weighted average shares · filed 2025-02-07 |
| 2022-12-31 | $0.21 derived: net income ÷ weighted average shares · filed 2025-02-07 | $0.46 derived: net income ÷ weighted average shares · filed 2025-02-07 | $0.73 derived: net income ÷ weighted average shares · filed 2025-02-07 | $1.01 10-K · filed 2025-02-07 |
| 2022-09-30 | $0.25 10-Q · filed 2023-10-27 | $0.52 derived: net income ÷ weighted average shares · filed 2023-10-27 | $0.80 10-Q · filed 2023-10-27 | $0.94 derived: net income ÷ weighted average shares · filed 2024-02-14 |
| 2022-06-30 | $0.28 10-Q · filed 2023-07-28 | $0.55 10-Q · filed 2023-07-28 | $0.69 derived: net income ÷ weighted average shares · filed 2024-02-14 | $0.92 derived: net income ÷ weighted average shares · filed 2024-02-14 |
| 2022-03-31 | $0.28 10-Q · filed 2023-04-28 | $0.41 derived: net income ÷ weighted average shares · filed 2024-02-14 | $0.65 derived: net income ÷ weighted average shares · filed 2024-02-14 | $0.88 derived: net income ÷ weighted average shares · filed 2024-02-14 |
| 2021-12-31 | $0.13 derived: net income ÷ weighted average shares · filed 2024-02-14 | $0.36 derived: net income ÷ weighted average shares · filed 2024-02-14 | $0.60 derived: net income ÷ weighted average shares · filed 2024-02-14 | $0.85 10-K · filed 2024-02-14 |
| 2021-09-30 | $0.24 10-Q · filed 2022-10-28 | $0.47 derived: net income ÷ weighted average shares · filed 2022-10-28 | $0.73 10-Q · filed 2022-10-28 | $0.79 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-06-30 | $0.24 10-Q · filed 2022-07-29 | $0.49 10-Q · filed 2022-07-29 | $0.55 derived: net income ÷ weighted average shares · filed 2023-02-14 | $0.46 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2021-03-31 | $0.25 10-Q · filed 2022-04-29 | $0.31 derived: net income ÷ weighted average shares · filed 2023-02-14 | $0.21 derived: net income ÷ weighted average shares · filed 2023-02-14 | $0.29 derived: net income ÷ weighted average shares · filed 2023-02-14 |
| 2020-12-31 | $0.06 10-K · filed 2021-02-16 | -$0.04 derived: net income ÷ weighted average shares · filed 2023-02-14 | $0.04 derived: net income ÷ weighted average shares · filed 2023-02-14 | $0.09 10-K · filed 2023-02-14 |
| 2020-09-30 | -$0.10 10-Q · filed 2021-10-29 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-10-29 | $0.03 10-Q · filed 2021-10-29 | |
| 2020-06-30 | $0.08 10-Q · filed 2021-07-30 | $0.13 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | $0.05 10-Q · filed 2021-04-28 | |||
| 2019-12-31 | $0.09 10-K · filed 2021-02-16 | -$0.84 10-K · filed 2022-02-11 | ||
| 2019-09-30 | $0.01 10-K · filed 2021-02-16 | -$1.13 10-Q · filed 2020-10-27 | ||
| 2019-06-30 | -$0.98 10-K · filed 2021-02-16 | -$1.73 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | -$0.59 10-K · filed 2021-02-16 | |||
| 2018-12-31 | -$0.94 10-K · filed 2020-02-14 | -$2.69 10-K · filed 2021-02-16 | ||
| 2018-09-30 | -$0.26 10-K · filed 2020-02-14 | |||
| 2018-06-30 | -$0.70 10-K · filed 2020-02-14 | |||
| 2018-03-31 | -$0.79 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |